Article

Combination of CK, LASEK may be useful for mild to moderate hyperopia

Paris—The combination of conductive keratoplasty (CK) for distance vision and hyperopic LASEK for near vision seems to be a safe and effective technique for the monovision correction of mild to moderate hyperopia, reported Marguerite McDonald, MD, at the annual meeting of the European Society of Cataract and Refractive Surgeons.

Dr. McDonald, from Tulane University, New Orleans, explained that CK was performed in the dominant eye (n = 12) for distance vision and conventional LASEK in the non-dominant eye (n = 11) for near vision.

The patients were an average of 55 years of age. The average uncorrected visual acuity (UCVA) in the eyes treated with CK was 20/63 and in the eyes treated with LASEK 20/60; the average UCVA at near in the eyes treated with LASEK was about J16. There was a slight increase in higher-order aberrations in the non-wavefront treated LASEK eyes.

At 3 months postoperatively, the average UCVA in the eyes treated with CK was 20/25 and 20/40 in the eyes treated with LASEK. The average UCVA at near in the eyes treated with LASEK was J1 and none was worse than J3.

There were no unexpected sight-threatening events in this pilot study, with the exception of one eye treated with LASEK that developed a bacterial infection because the patient did not use antibiotic drops postoperatively. This eye was not included in the analysis.

"The patients liked this treatment very much. This was a very small study that I am going to expand based on these results," Dr. McDonald commented.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.